Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS)

BACKGROUND: Recent evidence suggests that there may be a bidirectional, physiological link between hypogonadism and metabolic syndrome (MetS), and testosterone replacement therapy (TRT) has been shown to improve some symptoms of MetS in small patient populations. We examined the effect of 12 months...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhattacharya, Rajib K, Khera, Mohit, Blick, Gary, Kushner, Harvey, Nguyen, Dat, Miner, Martin M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217857/
https://www.ncbi.nlm.nih.gov/pubmed/22044661
http://dx.doi.org/10.1186/1472-6823-11-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217857/
https://www.ncbi.nlm.nih.gov/pubmed/22044661
http://dx.doi.org/10.1186/1472-6823-11-18

Ejemplares similares